Boston Trust Walden’s Core & Main CNM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.64M Sell
158,281
-34,912
-18% -$1.73M 0.06% 215
2026
Q1
$9.54M Sell
193,193
-2,391
-1% -$129K 0.08% 211
2025
Q4
$10.2M Sell
195,584
-7,955
-4% -$408K 0.08% 199
2025
Q3
$11M Buy
203,539
+9,258
+5% +$561K 0.08% 199
2025
Q2
$11.7M Sell
194,281
-8,289
-4% -$443K 0.08% 200
2025
Q1
$9.79M Buy
+202,570
New +$10.5M 0.07% 204

Other funds holding CNM

Boston Trust Walden's CNM Position: Q2 2026 in Review

Boston Trust Walden reduced its Core & Main (CNM) stake by 18% in Q2 2026, selling an estimated $1.73M and leaving 158,281 shares worth $7.64M. The position accounts for 0.06% of the portfolio, ranked #215.

Boston Trust Walden first reported a position in CNM in Q1 2025 and has held it in 6 quarters since. The position peaked at $11.7M in Q2 2025. 454 funds tracked by Wall St. Rank hold CNM as of Q2 2026.

  • Boston Trust Walden held 158,281 shares of Core & Main worth $7.64M as of Q2 2026.
  • Boston Trust Walden sold 34,912 Core & Main shares in Q2 2026, an estimated $1.73M.
  • Core & Main made up 0.06% of Boston Trust Walden's portfolio in Q2 2026, its #215 holding.
  • Boston Trust Walden first reported a position in Core & Main in Q1 2025 and has held it in 6 quarters since.
  • Boston Trust Walden's Core & Main position peaked at $11.7M in Q2 2025.
  • 454 funds tracked by Wall St. Rank held Core & Main as of Q2 2026.

Based on Boston Trust Walden's 13F filing for Q2 2026, filed 24 Jul 2026.